Stock Research for DVA

Current Price

$73.7000


Latest Update: 2018-02-16 16:00:00

High
$ 73.7200
Low
$ 73.6400
Close
$ 73.6500
Volume
21425
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

DVA Stock Chart & Research Data

The DVA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the DVA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


DVA Due diligence Resources & Stock Charts

The DVA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View DVA Detailed Price Forecast - CNN Money CNN View DVA Detailed Summary - Google Finance
Yahoo View DVA Detailed Summary - Yahoo! Finance Zacks View DVA Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View DVA Trends & Analysis - Trade-Ideas Barrons View DVA Major Holders - Barrons
NASDAQ View DVA Call Transcripts - NASDAQ Seeking View DVA Breaking News & Analysis - Seeking Alpha
Spotlight View DVA Annual Report - CompanySpotlight.com OTC Report View DVA OTC Short Report - OTCShortReport.com
TradeKing View DVA Fundamentals - TradeKing Charts View DVA SEC Filings - Bar Chart
WSJ View Historical Prices for DVA - The WSJ Morningstar View Performance/Total Return for DVA - Morningstar
MarketWatch View the Analyst Estimates for DVA - MarketWatch CNBC View the Earnings History for DVA - CNBC
StockMarketWatch View the DVA Earnings - StockMarketWatch MacroAxis View DVA Buy or Sell Recommendations - MacroAxis
Bullish View the DVA Bullish Patterns - American Bulls Short Pains View DVA Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View DVA Stock Mentions - StockTwits PennyStocks View DVA Stock Mentions - PennyStockTweets
Twitter View DVA Stock Mentions - Twitter Invest Hub View DVA Investment Forum News - Investor Hub
Yahoo View DVA Stock Mentions - Yahoo! Message Board Seeking Alpha View DVA Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for DVA - SECform4.com Insider Cow View Insider Transactions for DVA - Insider Cow
CNBC View DVA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for DVA - OTC Markets
Yahoo View Insider Transactions for DVA - Yahoo! Finance NASDAQ View Institutional Holdings for DVA - NASDAQ


Stock Charts

FinViz View DVA Stock Insight & Charts - FinViz.com StockCharts View DVA Investment Charts - StockCharts.com
BarChart View DVA Stock Overview & Charts - BarChart Trading View View DVA User Generated Charts - Trading View


Latest Financial News for DVA

DaVita eyes acquisitions, share buy-backs with cash windfall
Posted on Wednesday February 14, 2018

Flush with $4.9 billion in cash from the pending sale of its medical group and as much as $130 million in expected benefits from federal tax reform, DaVita Inc. CEO Kent Thiry said Tuesday that the company will look to repurchase shares, grow its kidney-care business and make “a limited number of investments” in other health-care companies. The comments came during a quarterly earnings call — the Denver-based kidney-care provider’s first since it announced the sale of its disappointing managed-care unit, DaVita Medical Group, in December to Optum. Thiry told the Denver Business Journal the day after the sale announcement that the company will look at the possible acquisition of companies in other areas of health care andt, already had begun looking at opportunities that it could integrate into its existing divisions.


DaVita (DVA) Beats Q4 Earnings Estimates, Misses Revenues
Posted on Wednesday February 14, 2018

Impressive results from Kidney Care business drove DaVita (DVA) in Q4.


DaVita Kidney Care Encourages Americans to Become Organ Donors
Posted on Wednesday February 14, 2018

DENVER, Feb. 14, 2018 /PRNewswire/ -- DaVita Kidney Care (DVA), a division of DaVita Inc. (DVA), a leading provider of kidney care services in the United States, supports National Donor Day and its patients with kidney disease by asking Americans to commit to organ donation. "Today, nearly 120,000 patients are on the waiting list to receive a life-saving organ transplant and more than 95,000 of those are waiting for a kidney," said Bryan Becker, MD, MMM, FACP, CEP, chief medical officer for DaVita Integrated Kidney Care.


DaVita Inc. (DVA) Q4 2017 Earnings Conference Call Transcript
Posted on Tuesday February 13, 2018

DVA earnings call for the period ending December 31, 2017.


DaVita Inc. 4th Quarter 2017 Results
PR Newswire (press release) - Feb 13, 2018
DaVita Inc. and its representatives may from time to time make written and oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 ("PSLRA"), including statements in this release, filings with the ...
DaVita HealthCare Partners Inc. Earnings Climb In Q4 - Markets Insider

DaVita Inc. Schedules 4th Quarter 2017 Investor Conference Call
PR Newswire (press release) - Jan 31, 2018
DENVER, Jan. 31, 2018 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading independent medical group and a leading provider of kidney care services in the United States, announced today that it will hold its quarterly conference call to discuss fourth ...
DaVita Kidney Care Promotes Heart-Healthy Lifestyles During American Heart Month - Markets Insider

Buy or Sell? What Analysts Recommends: DENTSPLY SIRONA Inc. (XRAY), DaVita Inc ...
StockNewsJournal - Feb 16, 2018
DaVita Inc. (NYSE:DVA), maintained return on investment for the last twelve months at 7.28, higher than what Reuters data shows regarding industry's average.

Davita Inc (NYSE:DVA) Position Decreased by Robeco Institutional Asset ...
The Ledger Gazette - 9 hours ago
Robeco Institutional Asset Management B.V. decreased its holdings in Davita Inc (NYSE:DVA) by 86.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC.
Davita Inc (NYSE:DVA) Position Reduced by PGGM Investments - StockNewsTimes
Davita Inc (DVA) Shares Bought by ING Groep NV - Dispatch Tribunal

Enter a stock symbol to view the stock details.